Position in ONC
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$310,047
-$241,375 QoQ
Shares Held
1,088
-68.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#185
of 282 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. ONC ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in ONC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,047 | 1,088 | Shares | Sole | 2026-07-27 | |
| 2022-06-30 | $551,422 | 3,407 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $218,021 | 1,156 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $379,302 | 1,400 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $685,344 | 1,888 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $310,243 | 904 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $277,419 | 797 | Shares | Sole | 2021-04-22 | |
| 2020-06-30 | $5,840 | 31 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||